Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank78
3Y CAGR-32.0%
5Y CAGR-33.7%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-32.0%/yr
Annual compound
5Y CAGR
-33.7%/yr
Consistent
Percentile
P78
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.13M | +149.0% |
| 2024 | $455000.00 | -57.0% |
| 2023 | $1.06M | -70.5% |
| 2022 | $3.60M | +310.3% |
| 2021 | $876442.00 | -90.1% |
| 2020 | $8.85M | - |
| 2019 | $0.00 | - |
| 2018 | $0.00 | -100.0% |
| 2013 | $300432.00 | -2.3% |
| 2012 | $307450.00 | - |